GlassScriptPhysician profile
Olubunmi Esan
NPI 1558795377
$14,440.49
in general payments reported to CMS, 2019-2025
16 companies · $1,648 in 2025
The $1,648 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $922 · 2020: $2,558 · 2021: $2,359 · 2022: $2,022 · 2023: $670 · 2024: $4,262 · 2025: $1,648.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $3,723 · Food and Beverage: $1,736 · Long Term Medical Supply Or Device Loan: $1,120.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $3,723.29 |
| Food and Beverage | $1,735.99 |
| Long Term Medical Supply Or Device Loan | $1,120.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Medtronic, INC. | $4,022.83 | 2021-2025 | Venaseal, Endurant Iis |
| Medtronic Vascular, INC. | $2,610.54 | 2019-2020 | |
| Terumo Medical Corporation | $2,196.19 | 2021-2023 | Glidewire |
| Bard Peripheral Vascular, INC. | $1,709.85 | 2021-2024 | Venclose Maven Catheter, Venovo |
| Angiodynamics, INC. | $1,151.43 | 2025 | Venacure 1470 Pro, Venacure 1470 Pro |
| Cook Medical LLC | $1,136.35 | 2020-2025 | Cook, Advance, Zilver Vena |
| W. L. Gore & Associates, INC. | $752.06 | 2019-2020 | |
| Boston Scientific Corporation | $232.20 | 2025 | Enroute Transcarotid Stent, Enroute Transcarotid Neuroprotection System |
| Inari Medical, INC. | $202.82 | 2023-2024 | Ct Thrombectomy System Kit, Flowtriever Catheter, S |
| Philips North America LLC | $139.70 | 2024 | (Bs0) Mechanical Atherectomy |
| Penumbra, INC. | $135.81 | 2021 | |
| Cardiovascular Systems INC. | $67.10 | 2022 | |
| Grifols USA, LLC | $30.93 | 2023 | Thrombate III |
| Becton, Dickinson and Company | $21.49 | 2025 | Covera |
| Stryker Corporation | $17.87 | 2025 | Artix Mt |
Show all 16 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $13.32 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Olubunmi Esan listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.